XML 55 R38.htm IDEA: XBRL DOCUMENT v3.26.1
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION
12 Months Ended
Dec. 31, 2025
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION  
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION

31.PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION

Condensed balance sheets

As at December 31

2024

2025

2025

  ​ ​ ​

RMB

  ​ ​ ​

RMB

  ​ ​ ​

US$

ASSETS

 

  ​

 

  ​

 

  ​

Current assets:

 

  ​

 

  ​

 

  ​

Cash and cash equivalent

 

409

336

48

Restricted cash

91

13

Prepayments and other current assets

73,592

77,546

11,089

Total current assets

 

74,001

77,973

11,150

Total assets

 

74,001

77,973

11,150

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

Current liabilities:

 

 

Short term loan

 

34,307

12,588

1,800

Long-term debts due within one year

84,482

49,469

7,074

Accrued expenses and other liabilities

 

67,300

68,001

9,724

Derivative liability

Amounts due to subsidiaries

 

2,337,986

2,051,025

293,293

Total current liabilities

 

2,524,075

2,181,083

311,891

Non-current liabilities:

Long-term bank and other borrowings, non-current portion

2,190

Total liabilities

 

2,526,265

2,181,083

311,891

Shareholders’ equity (deficit):

 

 

Class A ordinary shares (par value of US$0.0001per share; authorized shares-500,000,000; issued shares-96,565,584 and 96,565,584 as of December 31, 2024 and 2025; outstanding shares-84,463,737 and 84,463,737 as of December 31, 2024 and 2025, respectively)

 

68

68

10

Class B ordinary shares (par value of US$0.0001per share; authorized shares‑45,787,948; issued shares-45,787,948 and 45,787,948 as of December 31, 2024 and 2025; outstanding shares- 45,787,948 and 45,787,948 as of December 31, 2024 and 2025, respectively)

 

37

37

5

Treasury stock (12,101,847 and 12,101,847 shares as of December 31, 2024 and 2025, respectively)

 

(7)

(7)

(1)

Additional paid-in capital

 

2,169,693

2,438,000

348,629

Accumulated other comprehensive loss

 

(77,349)

(75,565)

(10,806)

Accumulated deficit

 

(4,544,706)

(4,465,643)

(638,578)

Total shareholders’ equity (deficit)

 

(2,452,264)

(2,103,110)

(300,741)

Total liabilities and shareholders’ equity (deficit)

 

74,001

77,973

11,150

Condensed statements of comprehensive loss

For the Years Ended December 31, 

2023

2024

2025

2025

  ​ ​ ​

RMB

  ​ ​ ​

RMB

  ​ ​ ​

RMB

  ​ ​ ​

US$

Revenues

 

Cost of revenues

 

General and administrative expenses

 

(2,414)

(2,642)

(2,469)

(353)

Selling expenses

 

Operating loss

 

(2,414)

(2,642)

(2,469)

(353)

Equity in loss of subsidiaries

 

(314,122)

(422,351)

(68,132)

(9,742)

Interest income

 

14

438

622

89

Interest expense

 

(9,926)

(47,314)

(3,979)

(569)

Changes in fair value of derivatives

 

5,282

168

Other income, net

(1,008)

Foreign exchange gain(loss)

 

24,516

(8,416)

(18,853)

(2,696)

Net loss

 

(297,658)

(480,117)

(92,811)

(13,271)

Other comprehensive income (loss)

 

Foreign currency translation, net of tax of nil

(6,480)

(7,630)

16,406

2,346

Unrealized losses on available-for-sale securities, net

(31,173)

(4,299)

(14,623)

(2,091)

Total other comprehensive (loss) income

 

(37,653)

(11,929)

1,783

255

Comprehensive loss

 

(335,311)

(492,046)

(91,028)

(13,016)

Condensed statements of cash flows

For the Years Ended December 31, 

2023

2024

2025

2025

  ​ ​ ​

RMB

  ​ ​ ​

RMB

  ​ ​ ​

RMB

  ​ ​ ​

US$

Net cash (used in) generated from operating activities

 

(1,258)

641

(2,304)

(329)

Net cash (used in) generated from investing activities

 

15,655

19,039

56,186

8,034

Net cash (used in) generated from financing activities

 

1,590

(37,226)

(53,847)

(7,700)

Exchange rate effect on cash

 

(31)

489

(17)

(2)

Net (decrease) increase in cash

 

15,956

(17,057)

18

3

Cash at beginning of the year

 

1,510

17,466

409

58

Cash and cash equivalents and restricted cash end of the year

 

17,466

409

427

61

Reconciliation of cash and cash equivalents and restricted cash to the consolidated balance sheets

Cash and cash equivalents

17,466

409

336

48

Restricted cash, current portion

91

13

Total cash and cash equivalents and restricted cash

17,466

409

427

61

Basis of presentation

For the presentation of the parent company only condensed financial information, the Company records its investment in subsidiaries under the equity method of accounting as prescribed in ASC 323, Investments - Equity Method and Joint Ventures. Such investment is presented on the balance sheet as “Investment in subsidiaries” and the subsidiaries profit or loss as “Equity in loss of subsidiaries” on the statements of comprehensive income loss. The parent company only financial statements should be read in conjunction with the Company’s consolidated financial statements.